Cargando…
Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario
Childhood cancer is considered rare, corresponding to ~3% of all malignant neoplasms in the human population. The World Health Organization (WHO) reports a universal occurrence of more than 15 cases per 100,000 inhabitants around the globe, and despite improvements in diagnosis, treatment and suppor...
Autores principales: | Candido, Marina Ferreira, Medeiros, Mariana, Veronez, Luciana Chain, Bastos, David, Oliveira, Karla Laissa, Pezuk, Julia Alejandra, Valera, Elvis Terci, Brassesco, María Sol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966033/ https://www.ncbi.nlm.nih.gov/pubmed/36839989 http://dx.doi.org/10.3390/pharmaceutics15020664 |
Ejemplares similares
-
G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future
por: Castro-Gamero, Angel Mauricio, et al.
Publicado: (2018) -
Clinical and cytogenetic aspects of giant cell tumor of the sternum
por: Engel, Edgard Eduard, et al.
Publicado: (2011) -
The Double Face of miR-708: A Pan-Cancer Player with Dissociative Identity Disorder
por: Carvalho de Oliveira, Jaqueline, et al.
Publicado: (2022) -
MiRNA Dysregulation in Childhood Hematological Cancer
por: Carvalho de Oliveira, Jaqueline, et al.
Publicado: (2018) -
Personalized Care for Patients with Cancer in the Precision-Medicine Era
por: Lopes-Júnior, Luís Carlos, et al.
Publicado: (2023)